Literature DB >> 1689366

An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself.

H Takahashi1, R N Germain, B Moss, J A Berzofsky.   

Abstract

We have observed that a peptide corresponding to an immunodominant epitope of the HIV-1 envelope protein recognized by class I MHC-restricted CD8+ CTL can also induce T cell help for itself. The help is necessary for restimulation of CTL precursors in vitro with peptide alone in the absence of exogenous lymphokines, can be removed by depletion of CD4+ T cells, and can be replaced by exogenous IL-2. Whereas the CTL in BALB/c or B10. D2 mice are restricted by the class I molecule Dd, the Th cells are restricted by the class II molecule Ad, and the help can be blocked by anti-Ad mAb. To examine the genetic regulation of the induction of help, we studied B10.A mice that share the class I Dd molecule, but have different class II molecules, Ak and Ek. Spleen cells of immune B10.A mice behave like CD4-depleted BALB/c spleen cells in that they cannot be restimulated in vitro by the peptide alone, but can with peptide plus IL-2. Therefore, in the absence of exogenous lymphokines, peptide-specific help is necessary for restimulation with this immunodominant CTL epitope peptide, and in H-2d mice, this peptide stimulates help for itself as well as CTL. We speculate on the implications of these findings for the immunodominance of this peptide in H-2d mice, and for the selective advantage of pairing certain class I and class II molecules in an MHC haplotype.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689366      PMCID: PMC2187719          DOI: 10.1084/jem.171.2.571

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

Review 1.  The structure of T-cell epitopes.

Authors:  A M Livingstone; C G Fathman
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

2.  Mapping of H-2 genes associated with T cell-mediated cytotoxic responses to SV40-tumour-associated specific antigens.

Authors:  K Pfizenmaier; G Trinchieri; D Solter; B B Knowles
Journal:  Nature       Date:  1978-08-17       Impact factor: 49.962

3.  A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules.

Authors:  F Sinigaglia; M Guttinger; J Kilgus; D M Doran; H Matile; H Etlinger; A Trzeciak; D Gillessen; J R Pink
Journal:  Nature       Date:  1988 Dec 22-29       Impact factor: 49.962

4.  Immunology. The ins and outs of antigen processing and presentation.

Authors:  R N Germain
Journal:  Nature       Date:  1986 Aug 21-27       Impact factor: 49.962

5.  Expression of the HTLV-III envelope gene by a recombinant vaccinia virus.

Authors:  S Chakrabarti; M Robert-Guroff; F Wong-Staal; R C Gallo; B Moss
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

6.  A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication.

Authors:  A Bhattacharya; M E Dorf; T A Springer
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

7.  An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

Authors:  H Takahashi; J Cohen; A Hosmalin; K B Cease; R Houghten; J L Cornette; C DeLisi; B Moss; R N Germain; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

8.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

9.  Identical peptides recognized by MHC class I- and II-restricted T cells.

Authors:  D L Perkins; M Z Lai; J A Smith; M L Gefter
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  33 in total

1.  In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.

Authors:  C Sedlik; G Dadaglio; M F Saron; E Deriaud; M Rojas; S I Casal; C Leclerc
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes.

Authors:  L C Dai; K West; R Littaua; K Takahashi; F A Ennis
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome.

Authors:  Srinika Ranasinghe; Michael Flanders; Sam Cutler; Damien Z Soghoian; Musie Ghebremichael; Isaiah Davis; Madelene Lindqvist; Florencia Pereyra; Bruce D Walker; David Heckerman; Hendrik Streeck
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

4.  Cross-reactive T-cell proliferative responses to V3 peptides corresponding to different geographical HIV-1 isolates in HIV-seropositive individuals.

Authors:  P N Nehete; P C Johnson; S J Schapiro; R B Arlinghaus; K J Sastry
Journal:  J Clin Immunol       Date:  1996-03       Impact factor: 8.317

5.  Suppression of major histocompatibility complex class II-associated invariant chain enhances the potency of an HIV gp120 DNA vaccine.

Authors:  Xueqing Lu; Shuzhen Wu; Catherine E Blackwell; Robert E Humphreys; Eric von Hofe; Minzhen Xu
Journal:  Immunology       Date:  2006-11-20       Impact factor: 7.397

6.  Molecular analysis of TCR and peptide/MHC interaction using P18-I10-derived peptides with a single D-amino acid substitution.

Authors:  Yohko Nakagawa; Hiroto Kikuchi; Hidemi Takahashi
Journal:  Biophys J       Date:  2007-01-05       Impact factor: 4.033

7.  A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus.

Authors:  T Shioda; S Oka; S Ida; K Nokihara; H Toriyoshi; S Mori; Y Takebe; S Kimura; K Shimada; Y Nagai
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1.

Authors:  S Li; V Polonis; H Isobe; H Zaghouani; R Guinea; T Moran; C Bona; P Palese
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.

Authors:  Beatrice Ondondo; Hayato Murakoshi; Genevieve Clutton; Sultan Abdul-Jawad; Edmund G-T Wee; Hiroyuki Gatanaga; Shinichi Oka; Andrew J McMichael; Masafumi Takiguchi; Bette Korber; Tomáš Hanke
Journal:  Mol Ther       Date:  2016-01-08       Impact factor: 11.454

10.  Identification of a dual-specific T cell epitope of the hemagglutinin antigen of an h5 avian influenza virus in chickens.

Authors:  Hamid R Haghighi; Leah R Read; S M Mansour Haeryfar; Shahriar Behboudi; Shayan Sharif
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.